H.C. Wainwright Genetic Medicines Virtual Conference

Add to calender
Investor

ProQR is participating in the H.C. Wainwright Genetic Medicines Virtual Conference – October 14-15, 2025.


Presentation available on demand beginning October 14 at 7:00 am ET and virtual 1x1s on October 15.  To access the presentation, please contact your H.C. Wainwright representative. 
 

You might like this

  • Press releases

    Read the latest news on our development programs, business updates and announcements. You can sign up for email alerts so you stay up to date on all things ProQR.

    Female scientist working in ProQR's laboratories

  • Our science

    Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments for people with genetic diseases.

    Axiomer RNA editing platform technology

  • About ProQR Therapeutics

    ProQR was founded by Daniel de Boer with a mission to help people living with rare genetic diseases. This remains the sole focus of our company today.

    Daniel de Boer wearing a blue suit stands with arm crossed in a laboratory setting.